Inventor · disambiguated record
John Van Der Oost
Also filed as: VAN DER OOST JOHN
20 granted patents·17 pending applications·68 citations·filing 2011–2025
93Inventor score
Files withUNIV WAGENINGEN19CARIBOU BIOSCIENCES INC10WEUSTHUIS ALEXANDER RUUD3PURAC BIOCHEM BV1TOTAL RES & TECHNOLOGY FELUY1
Top patents by PatentIndex Score
37 records- 0195US9885026B2Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2016·Granted Feb 6, 2018·34 cites·6 claims
- 0291US10954498B2Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2020·Granted Mar 23, 2021·2 cites·13 claims
- 0390US11242513B2Thermostable Cas9 nucleasesUNIV WAGENINGEN·Filed 2016·Granted Feb 8, 2022·6 cites·20 claims
- 0489US11326162B2Thermostable Cas9 nucleasesUNIV WAGENINGEN·Filed 2017·Granted May 10, 2022·5 cites·20 claims
- 0589US10711257B2Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2019·Granted Jul 14, 2020·2 cites·13 claims
- 0686US10731142B2Thermostable Cas9 nucleasesPURAC BIOCHEM BV·Filed 2016·Granted Aug 4, 2020·5 cites·17 claims
- 0786US10125375B2Methods of modifying a target nucleic acid with an ArgonauteCARIBOU BIOSCIENCES INC·Filed 2017·Granted Nov 13, 2018·3 cites·15 claims
- 0885US10435678B2Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2017·Granted Oct 8, 2019·3 cites·11 claims
- 0985US9902973B2Methods of modifying a target nucleic acid with an argonauteCARIBOU BIOSCIENCES INC·Filed 2014·Granted Feb 27, 2018·5 cites·12 claims
- 1077US11939604B2Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2021·Granted Mar 26, 2024·0 cites·13 claims
- 1176US11939605B2Thermostable CAS9 nucleasesUNIV WAGENINGEN·Filed 2022·Granted Mar 26, 2024·0 cites·19 claims
- 1276US11053482B2Vector systems for nuclease-mediated genome editingUNIV WAGENINGEN·Filed 2016·Granted Jul 6, 2021·1 cites·9 claims
- 1376US2025230424A1Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1476US2025327048A1Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1572US11479761B2Nuclease-mediated genome editingUNIV WAGENINGEN·Filed 2019·Granted Oct 25, 2022·0 cites·7 claims
- 1670US9777298B2Use of Monascus in organic acid productionWEUSTHUIS ALEXANDER RUUD·Filed 2011·Granted Oct 3, 2017·1 cites·15 claims
- 1770US8900834B2Process for polylactic acid production using monascusWEUSTHUIS ALEXANDER RUUD·Filed 2011·Granted Dec 2, 2014·1 cites·23 claims
- 1865US12071639B2Thermostable Cas9 nucleasesUNIV WAGENINGEN·Filed 2017·Granted Aug 27, 2024·0 cites·17 claims
- 1965US10190139B2Method for lactic acid production using Monascus strains modified for lactic acid productionTOTAL RES & TECHNOLOGY FELUY·Filed 2017·Granted Jan 29, 2019·0 cites·9 claims
- 2065US2015024499A1Modified cascade ribonucleoproteins and uses thereofUNIV WAGENINGEN·Filed 2014·Application pending·0 cites
- 2164US11976306B2Thermostable CAS9 nucleasesUNIV WAGENINGEN·Filed 2017·Granted May 7, 2024·0 cites·15 claims
- 2264US2025101497A1Thermostable RNA PolymeraseUNIV WAGENINGEN·Filed 2023·Application pending·0 cites
- 2362US11802277B2Thermostable Cas9 nucleasesUNIV WAGENINGEN·Filed 2020·Granted Oct 31, 2023·0 cites·21 claims
- 2461US2014294773A1Modified cascade ribonucleoproteins and uses thereofUNIV WAGENINGEN·Filed 2012·Application pending·0 cites
- 2560US2024026383A1Universal riboswitch for inducible gene expressionUNIV WAGENINGEN·Filed 2021·Application pending·0 cites
- 2658US2025145988A1Methods of enriching nucleic acidsUNIV WAGENINGEN·Filed 2023·Application pending·0 cites
- 2758US2024110163A1Crispr-associated based-editing of the complementary strandUNIV WAGENINGEN·Filed 2022·Application pending·0 cites
- 2855US9809831B2Monascus strains modified for organic acid productionWEUSTHUIS ALEXANDER RUUD·Filed 2011·Granted Nov 7, 2017·0 cites·13 claims
- 2953US2022325328A1Type III CRISPR/Cas-based DiagnosticsUNIV WAGENINGEN·Filed 2020·Application pending·0 cites
- 3051US2022372455A1Crispr type v-u1 system from mycobacterium mucogenicum and uses thereofUNIV WAGENINGEN·Filed 2020·Application pending·0 cites
- 3150US2025250641A1Methods and compositions related to epigenetic editing by a methlylation-dependent cas9UNIV FLORIDA STATE RES FOUND·Filed 2025·Application pending·0 cites
- 3247US2025223578A1Modified cascade ribonucleoproteins and uses thereofCARIBOU BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3346US2021010064A1Enrichment of nucleic acidsUNIV PENNSYLVANIA·Filed 2019·Application pending·0 cites
- 3443US2020291368A1Improved CRISPR-Cpf1 Genome Editing ToolUNIV WAGENINGEN·Filed 2017·Application pending·0 cites
- 3543US2020291369A1Improved CRISPR-Cas9 Genome Editing ToolUNIV ERASMUS MED CT ROTTERDAM·Filed 2017·Application pending·0 cites
- 3643US2019292537A1Prokaryotic Argonaute Proteins and Uses ThereofUNIV WAGENINGEN·Filed 2017·Application pending·0 cites
- 3740US2018119156A1Riboswitch inducible gene expressionUNIV WAGENINGEN·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Van Der Oost files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →